Previous close | 96.89 |
Open | 96.68 |
Bid | 90.18 x 800 |
Ask | 100.00 x 800 |
Day's range | 94.14 - 97.29 |
52-week range | 45.38 - 102.33 |
Volume | |
Avg. volume | 682,254 |
Market cap | 4.774B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Glaukos' (GKOS) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
While Glaukos Corporation ( NYSE:GKOS ) might not have the largest market cap around , it received a lot of attention...